Goyal, L., Lamarca, A., Shroff, R., Ueno, M., Vogel, A., Zhou, J., Chen, X., Kayhanian, H., Laskowska-Macios, K., Zhao, F., Yoo, C. (2026). ARTEMIDE-Biliary02: A phase 3, randomized, global study of rilvegostomig or durvalumab with chemotherapy as first-line (1L) treatment for advanced biliary tract cancer (BTC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4253